How many shots are needed? Can I give it even if it’s beyond the age indication? My patient is immunocompromised—when do I ...

The University of Missouri Extension wants to spread awareness of alpha-gal syndrome. The MU Extension held a free workshop ...

U.S. net product revenue for the three and nine months ended September 30, 2025 was $40.7 million and $115.8 million, respectively, compared to $31.1 million and $84.2 million, for the comparable ...

Fire ants are a major biosecurity threat that can decimate crops, kill livestock and cause potentially deadly allergic ...

Get key insights from Aquestive Therapeutics Q3 2025 earnings: Anaphylm launch prep, strong financing, FDA outlook, and market disruption.

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

The FDA has accepted for Priority Review the sBLA for pegvaliase-pqpz in adolescents aged 12 to 17 years with phenylketonuria.

Eaten in moderation, peanut butter can offer several health benefits. The best time to eat peanut butter may depend on your individual goals.

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...

Ionis Pharmaceuticals, Inc. today announced new long-term data for DAWNZERAtm (donidalorsen), the first and only RNA-targeted prophylactic medicine for hereditary angioedema (HAE), to be presented at ...

Analysts estimate that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.47. ARS Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...